
    
      Patient receives preparative therapy including cyclophosphamide and total body irradiation
      (TBI) of 10 Gy or total marrow and lymphoid irradiation (TMLI) of 12-20 Gy, and starts
      immunosuppressive therapy using cyclosporine or tacrolimus, methotrexate-based prophylaxes,
      followed by peripheral blood stem cell transplantation and granulocyte colony-stimulating
      factor administration.
    
  